Sign In
Buy GRFS
$7.18
-0.100 (-1.37%)
At Close: Jun 23, 2026
Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
08:00am, Monday, 15'th Jun 2026
BARCELONA, Spain, June 15, 2026 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading producer of plasma-derived medicines, today announced the U.S. la
Grifols: Plasma Self-Sufficiency Is The Mispriced Catalyst
07:18am, Thursday, 04'th Jun 2026
Grifols is transitioning from a leveraged recovery story to a strategic plasma infrastructure leader with global scale and supply security advantages. GRFS trades at a significant valuation discount�
Grifols, S.A. (GIKLY) Q1 2026 Earnings Call Transcript
03:31pm, Saturday, 09'th May 2026
Grifols, S.A. (GIKLY) Q1 2026 Earnings Call Transcript
Aldeyra Therapeutics (NASDAQ:ALDX) and Grifols (NASDAQ:GRFS) Head to Head Comparison
01:26am, Monday, 13'th Apr 2026
Aldeyra Therapeutics (NASDAQ: ALDX - Get Free Report) and Grifols (NASDAQ: GRFS - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses
Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates
05:31pm, Monday, 30'th Mar 2026
OTTAWA, March 30, 2026 (GLOBE NEWSWIRE) -- Proponents of public universal health care across Canada are calling for the closure of Grifols facilities in the wake of two deaths in Winnipeg of people wh
Grifols approves IPO of its US biopharma business
05:11pm, Tuesday, 24'th Mar 2026
Healthcare company Grifols said on Tuesday it has approved a U.S. initial public offering of its U.S. biopharma business.
Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson's Disease
08:28am, Tuesday, 17'th Mar 2026
BARCELONA, Spain, March 17, 2026 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading producer of plasma-derived medicines, today shared proof-of-conc
TORONTO, March 13, 2026 (GLOBE NEWSWIRE) -- The Ontario and Manitoba Health Coalitions held a press conference this morning to respond to a report from CBC about two patients who died in Winnipeg
Media Advisory: Press Conference Regarding Tragic Deaths After Plasma Harvesting at Grifols' Sites
06:01pm, Thursday, 12'th Mar 2026
WINNIPEG, Manitoba and TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- What: Spokespeople from the Manitoba Health Coalition and Ontario Health Coalition will respond to the sad news of two deaths of paid
Grifols: I'm Very Happy To Add In 2026
09:36pm, Wednesday, 11'th Mar 2026
Grifols is a global leader in blood plasma, now rated 'BUY' with a €20/share PT and $23/share ADR target. GRFS has delivered €450M in cost savings, 150%+ net profit growth, and FCF exceeding guida
Diversify Wealth Management LLC Takes Position in Grifols, S.A. $GRFS
04:21am, Sunday, 01'st Mar 2026
Diversify Wealth Management LLC bought a new position in Grifols, S.A. (NASDAQ: GRFS) during the undefined quarter, according to its most recent filing with the SEC. The institutional investor bought
Grifols, S.A. (GIKLY) Q4 2025 Earnings Call Transcript
05:27pm, Thursday, 26'th Feb 2026
Grifols, S.A. (GIKLY) Q4 2025 Earnings Call Transcript
Grifols doubles net profit in 2025, driven by revenues
11:55am, Thursday, 26'th Feb 2026
Spanish drugmaker Grifols reported on Thursday a net profit of 402 million euros ($473.96 million) for 2025, more than double what it recorded the previous year, driven by revenues of 7.5 billion euro
Grifols (GRFS) Expected to Announce Quarterly Earnings on Wednesday
04:10am, Monday, 23'rd Feb 2026
Grifols (NASDAQ: GRFS - Get Free Report) is projected to issue its Q4 2025 results before the market opens on Wednesday, February 25th. Analysts expect the company to announce earnings of $0.29 per sh
Brandes Investment Partners, LP's Strategic Moves: Progressive Corp Leads with 1.04% Portfolio Impact
03:02pm, Wednesday, 11'th Feb 2026
Insightful Analysis of Brandes Investment Partners, LP (Trades, Portfolio)'s Fourth Quarter 2025 13F Filing Brandes Investment Partners, LP (Trades, Portfolio)
